Notice of Cancellation of the April 2022 Application Receipt Date for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed"
Notice Number:
NOT-FD-22-002
Release Date:
December 6, 2021
PAR-20-105 - Laboratory Flexible Funding Model (LFFM) (U19 Clinical Trials Not Allowed)
U.S. Food and Drug Administration (FDA)
The purpose of this Notice is to announce the cancellation of the April 6, 2022 application due date for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19 Clinical Trials Not Allowed)". Applications will not be received or considered for the April 6, 2022 application due date.
Kiara Farmer
Grants Management Specialist
Office of Operations, Office of Finance Budget & Acquisitions
Office of Acquisitions and Grant Services, HFA-500
U.S. Food and Drug Administration
Tel: 240-402-3099
Email: Kiara.Farmer@fda.hhs.gov
Department of Health
and Human Services (HHS)
and Human Services (HHS)
